Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marek Los

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Trends in Molecular Medicine|September 9, 2008
Cancer stem cell markers in common cancers - therapeutic implicationsThomas Klonisch, Emilia Wiechec, Sabine Hombach-Klonisch, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|October 3, 2006
Methods and biomarkers for the diagnosis and prognosis of cancer and other diseases: towards personalized medicineJudy E Anderson, Lise Lotte Hansen, Frank C Mooren, et al.
European Journal of Pharmacology|August 21, 2007
9-Benzylidene-naphtho[2,3-b]thiophen-4-ones and benzylidene-9(10H)-anthracenones as novel tubulin interacting agents with high apoptosis-inducing activityAnne Zuse, Helge Prinz, Klaus Müller, et al.
Expert Opinion on Therapeutic Targets|March 22, 2006
The emerging importance of DNA mapping and other comprehensive screening techniques, as tools to identify new drug targets and as a means of (cancer) therapy personalisationTadeusz J Kroczak, Jaroslaw Baran, Juliusz Pryjma, et al.
Molecular Biology of the Cell|March 22, 2002
Activation and caspase-mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signalingMarek Los, Malgorzata Mozoluk, Davide Ferrari, et al.
Neoplasia (New York, N.Y.)|September 25, 2008
The cytoplasmic domain of proEGF negatively regulates motility and elastinolytic activity in thyroid carcinoma cellsAleksandra Glogowska, Janette Pyka, Astrid Kehlen, et al.
Archivum Immunologiae Et Therapiae Experimentalis|July 13, 2004
Stroke, myocardial infarction, acute and chronic inflammatory diseases: caspases and other apoptotic molecules as targets for drug developmentMichael Kreuter, Claus Langer, Claus Kerkhoff, et al.
International Journal of Cancer|April 1, 2005
Serum cytochrome c indicates in vivo apoptosis and can serve as a prognostic marker during cancer therapyKatarzyna Barczyk, Michael Kreuter, Juliusz Pryjma, et al.
Journal of Leukocyte Biology|March 15, 2008
S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathwaySaeid Ghavami, Iran Rashedi, Brian M Dattilo, et al.
Journal of Molecular Medicine (Berlin, Germany)|July 17, 2008
Adult stem cells and their trans-differentiation potential--perspectives and therapeutic applicationsSabine Hombach-Klonisch, Soumya Panigrahi, Iran Rashedi, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Trends in Molecular Medicine|September 9, 2008
Cancer stem cell markers in common cancers - therapeutic implicationsThomas Klonisch, Emilia Wiechec, Sabine Hombach-Klonisch, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|October 3, 2006
Methods and biomarkers for the diagnosis and prognosis of cancer and other diseases: towards personalized medicineJudy E Anderson, Lise Lotte Hansen, Frank C Mooren, et al.
European Journal of Pharmacology|August 21, 2007
9-Benzylidene-naphtho[2,3-b]thiophen-4-ones and benzylidene-9(10H)-anthracenones as novel tubulin interacting agents with high apoptosis-inducing activityAnne Zuse, Helge Prinz, Klaus Müller, et al.
Expert Opinion on Therapeutic Targets|March 22, 2006
The emerging importance of DNA mapping and other comprehensive screening techniques, as tools to identify new drug targets and as a means of (cancer) therapy personalisationTadeusz J Kroczak, Jaroslaw Baran, Juliusz Pryjma, et al.
Molecular Biology of the Cell|March 22, 2002
Activation and caspase-mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signalingMarek Los, Malgorzata Mozoluk, Davide Ferrari, et al.
Neoplasia (New York, N.Y.)|September 25, 2008
The cytoplasmic domain of proEGF negatively regulates motility and elastinolytic activity in thyroid carcinoma cellsAleksandra Glogowska, Janette Pyka, Astrid Kehlen, et al.
Archivum Immunologiae Et Therapiae Experimentalis|July 13, 2004
Stroke, myocardial infarction, acute and chronic inflammatory diseases: caspases and other apoptotic molecules as targets for drug developmentMichael Kreuter, Claus Langer, Claus Kerkhoff, et al.
International Journal of Cancer|April 1, 2005
Serum cytochrome c indicates in vivo apoptosis and can serve as a prognostic marker during cancer therapyKatarzyna Barczyk, Michael Kreuter, Juliusz Pryjma, et al.
Journal of Leukocyte Biology|March 15, 2008
S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathwaySaeid Ghavami, Iran Rashedi, Brian M Dattilo, et al.
Journal of Molecular Medicine (Berlin, Germany)|July 17, 2008
Adult stem cells and their trans-differentiation potential--perspectives and therapeutic applicationsSabine Hombach-Klonisch, Soumya Panigrahi, Iran Rashedi, et al.
Pageof 6